Showing results (1481-1490 of 14,091) with videos related to
Sort By:
Pageof 1,410
Gynecologic Oncology|October 16, 2007
Protease-activated receptor-2 (PAR-2) in cervical cancer proliferationPedro Ernesto Sánchez-Hernández, Maria Guadalupe Ramirez-Dueñas, Benibelks Albarran-Somoza, et al.Gynecologic Oncology|October 9, 2007
A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cellsMee Young Ahn, Jee H Jung, Yong Jin Na, et al.Gynecologic Oncology|November 22, 2007
MRgFUS for pain relief as palliative treatment in recurrent cervical carcinoma: a case reportR Machtinger, Y Inbar, G Ben-Baruch, et al.Gynecologic Oncology|November 22, 2007
A patient with bilateral immature ovarian teratoma presenting with paraneoplastic encephalitisAnne M van Altena, Geertruida J Wijnberg, Eva Kolwijck, et al.Gynecologic Oncology|November 27, 2007
Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinomaMarkéta Tomsová, Bohuslav Melichar, Iva Sedláková, et al.Gynecologic Oncology|September 30, 2008
Nevirapine induces growth arrest and premature senescence in human cervical carcinoma cellsKonstantinos Stefanidis, Dimitris Loutradis, Leandros-Vassilios Vassiliou, et al.Gynecologic Oncology|August 8, 2008
What women with ovarian cancer think and know about genetic testingRobin A Lacour, Molly S Daniels, Shannon N Westin, et al.Gynecologic Oncology|June 1, 1991
Early stage I adenocarcinoma of the uterine cervix: treatment results in patients with tumors less than or equal to 4 cm in diameterP J Eifel, T W Burke, L Delclos, et al.Gynecologic Oncology|June 11, 1991
Late effects of cisplatin-based chemotherapy on renal function in patients with ovarian carcinomaM Markman, R Rothman, T Hakes, et al.Gynecologic Oncology|June 1, 1991
Cytoreduction of diaphragmatic metastases using the Cavitron Ultrasonic Surgical AspiratorM D AdelsonPageof 1,410